Solutions

Rilemo develops portable medical diagnostic
and monitoring devices
based on non-ionising
safe electromagnetic imaging

Product

Bringing diagnostics to Anyone, Anywhere


Rilemo developed a portable medical imaging device to help doctors get fast, accurate diagnosis of fluid related pathologies in and outside the radiology department, in ambulances, as well as directly on the field.

Rilemo streamlines the patient journey by enabling all Doctors to take 3D images to clearly identify the presence of water, blood, or other liquids in their patients. This is made possible thanks to Electromagnetic Imaging, a technique using safe non-ionising waves.

These waves, similar in frequency and power to WiFi, pose no danger to patients, and medical staff, making the usage of Rilemo possible in any environment without cumbersome procedures as needed with X-Rays.

Similar to a tablet, Rilemo’s device emits safe electromagnetic waves towards the patient. The waves are then reflected back to the device by fluids as water and blood. Once the reflection is received back, a colour image is formed, showing both anatomical, and functional data to doctors.

Key Highlights

Key
Highlights

~1.5 kg

Rilemo’s devices are as portable as a laptop, enabling every doctor or nurse
to transport, and use them anywhere.

Rilemo’s devices are as portable as a laptop, enabling every doctor or nurse to transport, and use them anywhere.

Rilemo’s devices are as portable as a laptop, enabling every doctor or nurse to transport, and use them anywhere.

300+

scans can be captured with one battery charge, ideal for urgent scenarios where downtime is unacceptable.

90%

lower hospital spending for inconclusive results and unnecessary therapy, lowering inefficiencies & CO2 emissions [5]

Technology

A safe technology for every clinician & patient

Rilemo’s Electromagnetic (EM) Imaging was developed with a safety first approach by employing intrinsically safe EM waves found in smartphones, and even in children’s monitor cameras or toys.

These waves, as for example in smartphones, are limited to reach a SAR level of 1600mW/kg, which is a measure of how much they can warm the body of a person while making a call. Rilemo’s devices instead reach a SAR no higher than 200mW/kg, 8x lower than a smartphone.

Ultimately, Rilemo’s devices are also designed to be used in conjunction with CT scans and X-Ray systems. In this way medical doctors are able to seamlessly continue with their visits, while enjoying a crucial additional layer of information, reducing inefficiencies, length of stays and mortality.

Papers and technical documentation

Papers
and technical
docs

Product Overview

Product Overview

Technical Overview

Technical Overview

More info available under request

More info available under request

Team

Meet the Rilemo team

Discover the Rilemo team, a group of passionate professionals and innovators dedicated to perfecting our product every day.

Discover the Rilemo team, a group of passionate professionals and innovators dedicated to perfecting our solutions every day.

This website is intended for healthcare professionals and investors for informational purposes only and does not provide medical advice. Our products are in development and not yet approved by regulatory authorities, including the FDA (U.S.) and CE certification (EU MDR 2017/745). All product descriptions are based on early research. We are committed to meeting applicable standards, including ISO 13485, before release. For medical concerns, consult a licensed healthcare professional. Use of this website is at your own risk, and Rilemo s.r.l. disclaims any liability for reliance on the information provided.

© 2025 Rilemo s.r.l. All Rights Reserved

Rilemo s.r.l.
VAT: IT04187140134
REA: LC - 426250
Legal Address: Via Don Sebastiano Colleoni 20, Robbiate (LC), Italy
Capital: 10.000 €, Paid-in: 3.500 €© 2025 Rilemo s.r.l. All Rights Reserved

This website is intended for healthcare professionals and investors for informational purposes only and does not provide medical advice. Our products are in development and not yet approved by regulatory authorities, including the FDA (U.S.) and CE certification (EU MDR 2017/745). All product descriptions are based on early research. We are committed to meeting applicable standards, including ISO 13485, before release. For medical concerns, consult a licensed healthcare professional. Use of this website is at your own risk, and Rilemo s.r.l. disclaims any liability for reliance on the information provided.

© 2025 Rilemo s.r.l. All Rights Reserved

Rilemo s.r.l.
VAT: IT04187140134
REA: LC - 426250
Legal Address: Via Don Sebastiano Colleoni 20, Robbiate (LC), Italy
Capital: 10.000 €, Paid-in: 3.500 €

This website is intended for healthcare professionals and investors for informational purposes only and does not provide medical advice. Our products are in development and not yet approved by regulatory authorities, including the FDA (U.S.) and CE certification (EU MDR 2017/745). All product descriptions are based on early research. We are committed to meeting applicable standards, including ISO 13485, before release. For medical concerns, consult a licensed healthcare professional. Use of this website is at your own risk, and Rilemo s.r.l. disclaims any liability for reliance on the information provided.

© 2025 Rilemo s.r.l. All Rights Reserved

Rilemo s.r.l.
VAT: IT04187140134
REA: LC - 426250
Legal Address: Via Don Sebastiano Colleoni 20, Robbiate (LC), Italy
Capital: 10.000 €, Paid-in: 3.500 €